AUS
NZ
UK
CA
USA
IND
Highlights:
- Blis Technologies renews focus on its core business strength
- With the aim of returning to profitability, it will focus on B2Bs and international markets
- It has announced a few senior leadership changes
Dunedin-based Blis Technologies Limited (NZX:BLT) is a well-known name across New Zealand’s healthcare space. It is a biotech company, which was launched in 2000, and is engaged in developing and supplying advanced probiotics for the mouth and throat.
Source: © Dkessaris | Megapixl.com
Refocused core business strategy
Following a lukewarm FY22 performance, Blis Technologies took a review of its existing business strategy and renewed its focus on its core business, particularly its global B2B partners, which will drive scale and help the Company to return to profitability.
Upcoming Partnerships
The biotechnology company has stated that it will now have a narrower operational focus on B2B and lay more emphasis on establishing partnerships with proven industry operators to commercialise its innovative probiotic solutions technology. In other words, BLT will make a shift from direct selling to consumers by the end of next year other than in countries like NZ and the US Amazon platform.
Identification of key markets
The company claims to have identified markets and channels that continue to work well and aims to develop partnerships with firms that are better placed in the long run, thus leveraging each other’s strengths and delivering enhanced profitability.
Focus on R&D
Blis Technologies remains focused on research and development, which is its core strength. It boasts a pipeline of opportunities that are of significant commercial importance to its partners and will help Blis to stay ahead in the field of probiotic innovation.
Changes in Executive team
In line with its refreshed strategy on core business, Jennifer Walker has been appointed as Blis Technologies’ CRO, i.e., Chief Revenue Officer. Her job role will include overseeing all the revenue streams and integrating the sales and marketing activity. She had earlier served as the Company’s Marketing and eCommerce Director.
Further, BLT’s Commercial Director will now report to Chief Revenue Officer and will not be a part of its senior leadership team.
Bottom Line
Blis Technologies Limited has claimed that it is focused on capitalising its core strengths and is committed to develop partnerships with proven industry experts, which will help in expanding its market presence and enhance its profitability.
On 13 September, at the time of writing, Blis Technologies was rising 6.90% to NZ$0.031.